Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

25.44
Delayed Data
As of Jun 29
 +1.62 / +6.80%
Today’s Change
18.52
Today|||52-Week Range
69.45
-15.62%
Year-to-Date
Intrexon and Zika Virus: An Interview With Oxitec's Hadyn Parry
Jun 28 / MotleyFool.com - Paid Partner Content
Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Jun 21 / Zacks.com - Paid Partner Content
The $100 Million Platform Intrexon Investors Forgot
Jun 27 / MotleyFool.com - Paid Partner Content
Why Intrexon Won't Commercialize Fuels by 2018
Jun 20 / MotleyFool.com - Paid Partner Content
3 Stocks Investing in This Under-the-Radar Growth Opportunity
Jun 24 / MotleyFool.com - Paid Partner Content
Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.
Jun 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close23.82
Today’s open24.02
Day’s range23.54 - 25.60
Volume1,466,156
Average volume (3 months)2,041,548
Market cap$2.8B
Dividend yield--
Data as of 4:01pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-71.38%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book4.00

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+0.59+2.67%
KITEKite Pharma Inc+0.11+0.22%
NVAXNovavax Inc+0.20+2.87%
OPHTOphthotech Corp+0.30+0.58%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers

Search for Jobs